Legend Biotech

US · LEGN #2374 by market cap Listed 2020

19.12 +0.40 +2.14%

Live - 5344 symbols - heartbeat 319s ago · 2026-10-08 06:23

Pre-market 19.19 +0.37%

After-hours 19.20 +0.42%

Overnight 19.25 +0.68%

Market cap: 3.72B
P/E (TTM): -38.24
P/B: 3.02
EPS: -1.62
Div yield: 0.00%
52W pos: 14%

Reader sentiment Are you bullish or bearish on LEGN?

Anonymous reader poll. Unscientific, not investment advice.

About Legend Biotech

Legend Biotech Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, manufacturing, and commercialization of novel therapies for oncology and other indications. The firm develops advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell and natural killer cell-based immunotherapy. It operates through the following geographical segments: United States of America, China, and Other. The company was founded in 2014 and is headquartered in Somerset, NJ.

Founded: 2014
CEO: Dr. Ying Huang, PhD
Employees: 2,900
Headquarters: Somerset, New Jersey, United States of America
Fiscal year end: 12-31
Website: legendbiotech.com

Company profile

Exchange: US
Symbol: LEGN
Market-cap rank: #2374
Listing date: 2020-06-05
Market cap: 3.72B
Float cap: 3.71B
Shares out: 194.49M
Float shares: 194.26M

Sectors & themes

Biotechnology China Concept Stocks Fractional Shares JP

Browse all sectors & themes

Quote time 2026-10-08 06:23:44 · For reference only, not investment advice and not tailored to your situation.